Downregulation of Ang II expression by blocking the conversion of angiotensin I (Ang I) to Ang II using an angiotensin-converting enzyme inhibitor (ACEI) prevents cardiac function deterioration from HF in hypertensive patients (Zhang et al., 2019). This evidence concerns the gene AGT and hydrops fetalis.